Palo Alto, CANCT05837845Now EnrollingIRB Ready

PTSD Clinical Trial in Palo Alto, CA

Access cutting-edge ptsd treatment through this phase 2 clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Patricia Suppes

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions…

Expert Care in Palo Alto

Access ptsd specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ptsd treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this ptsd clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This PTSD Study in Palo Alto

In partnership with the Veterans Affairs (VA) Palo Alto Health Care System and Stanford University, this study aims to evaluate clinical outcomes, assess implementation feasibility, and health economics of MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) in the treatment of posttraumatic stress disorder (PTSD). Through a randomized comparison of MDMA-aCPT versus Cognitive Processing Therapy (CPT), a VA gold standard treatment for PTSD, the proposed study will set the stage for understanding the potential use and application of MDMA-aCPT for PTSD within the VA system.

Sponsor: Patricia Suppes

Who Can Participate

Inclusion Criteria

Participants are eligible to be included in the study only if all of the following criteria apply:
Are at least 18 years at the time of signing the informed consent
Are a U.S Military Veteran
Are receiving services from VA Palo Alto Healthcare System, VA San Francisco Healthcare System, or VA NorCal Healthcare System
Are fluent in speaking and reading in English
Agree to have study visits audio and/or video recorded
If assigned to MDMA-aCPT, able to identify appropriate support person(s) to stay with the participant on the evenings of the MDMA sessions
Meet DSM-5 criteria for PTSD with a symptom duration of at least 6 months
Have severe PTSD symptoms in the last month
Body weight of at least 48 kilograms (kg)
Is not pregnant, planning to get pregnant, or breastfeeding
Capable of giving signed informed consent

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:
Have a history of any medical condition that could make receiving a sympathomimetic drug harmful
Have current unstable medical illness
Have cardiac conditions, including uncontrolled hypertension, prolonged QTc interval, and other cardiac conditions
Have received Electroconvulsive Therapy (ECT), ketamine-assisted therapy, or used ketamine within 12 weeks of enrollment
Moderate or severe alcohol or cannabis use disorder within the last 12 months
Active illicit drug (other than cannabis) or prescription drug substance use disorder at any severity within the last 12 months
Have current serious suicide risk
Unable or unwilling to stop or safely taper off prohibited medications
Have used MDMA (ecstasy) ever
Currently enrolled in any clinical study
Personal history of primary psychotic disorder, type I bipolar disorder, severe personality disorder, eating disorder with compensatory behaviors, or depressive disorder with psychotic features
Lack social support, or lack a stable living situation

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT05837845) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

PTSD Treatment Options in Palo Alto, CA

If you're searching for ptsd treatment options in Palo Alto, CA, this clinical trial (NCT05837845) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced ptsd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ptsd clinical trials near you to find additional studies recruiting in your area.

More PTSD Trials in Palo Alto, CA

See all ptsd clinical trials recruiting in Palo Alto — not just this study.

Browse PTSD Trials in Palo Alto →

Browse More Trials by Condition

PTSD TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA